Skip to main content

Jessica Hagen

Jessica Hagen
By Jessica Hagen | 02:59 pm | December 03, 2025
The company said the acquisition allows it to begin delivering a comprehensive stepped care model that incorporates group therapy and peer support.
By Jessica Hagen | 11:53 am | December 03, 2025
The company closed after failing to secure additional investment due to regulatory uncertainty and delayed action on extending the Acute Hospital Care at Home Waiver Program.
By Jessica Hagen | 05:00 pm | December 02, 2025
Dr. Ronald Whelan, CEO of South Africa's Discovery Health, discusses how the insurer uses a shared-value model supported by wearables, data and rewards to incentivize healthier habits.
By Jessica Hagen | 02:00 pm | December 02, 2025
ACCESS is a decade-long initiative to expand tech-enabled care and outcome-based payments for Medicare patients with obesity, diabetes, chronic pain and depression.
By Jessica Hagen | 03:20 pm | December 01, 2025
Ciba Health collaborates with Canadian health benefits administrator Quikcard, and Octave Bioscience signs a partnership agreement with Quest Diagnostics.
By Jessica Hagen | 09:36 am | December 01, 2025
The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.
By Jessica Hagen | 03:54 pm | November 26, 2025
Stephen Klasko, executive in residence at General Catalyst, shares how AI, innovation, economic realities and revamped medical training will shape healthcare and longevity.
By Jessica Hagen | 05:24 pm | November 25, 2025
The Elton John AIDS Foundation, one of the first financial backers of Zipline and an established partner of the company, made the announcement.
By Jessica Hagen | 11:39 am | November 25, 2025
The Greek government will integrate Sword Intelligence into the country's National Health Information Line to workers with triage and care coordination.
By Jessica Hagen | 06:22 pm | November 24, 2025
Nest Health closes a $22.5 million Series A round, and Revian secures $13 million in funding for its hair growth device.